CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioRegen Biomedical (Changzhou) Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioRegen Biomedical (Changzhou) Co Ltd
Block B
No. 117 Xueye Road, Xinbei Dis
Phone: +86 51988408555p:+86 51988408555 CHANGZHOU, JNG  213125  China Ticker: 920201920201

Business Summary
BioRegen Biomedical (Changzhou) Co., Ltd. is a China-based company principally engaged in the research and development, production, and sale of biomedical materials and related products. The Company operates its businesses through two segments. The Medical Devices segment is mainly engaged in the research and development, production, and sale of medical device products. The Functional Skincare Products segment is mainly engaged in the research and development, production, and sale of functional skincare products. The Company's main products are applied in post-operative wound healing and tissue repair fields, including uterine, pelvic (abdominal), and nasal (sinus) cavities. The Company mainly operates its businesses in the domestic market.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202512/31/2025-----

General Information
Number of Employees: 240 (As of 12/31/2025)
Outstanding Shares: 68,225,832 (As of 9/24/2026)
Stock Exchange: BJS
Fax Number: +86 51988407911


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 15, 2026